NCT04755777已完成不适用
Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill: a Multicenter Mixed-methods Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Mayo Clinic
- 入组人数
- 138
- 试验地点
- 3
- 主要终点
- Frequency of drug level testing recommended
研究概览
简要总结
The purpose of the study is to characterize various healthcare practitioners' perspectives on implementation of beta-lactam therapeutic drug monitoring in critical care practice.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Providers involved with beta-lactam TDM for critically ill patients
排除标准
- 未提供
结局指标
主要结局
Frequency of drug level testing recommended
时间窗: Baseline
Indication of how many critically ill patients treated with beta-lactams should receive TDM.
Nature of drug level testing recommended
时间窗: Baseline
Indication of which types of critically ill patients treated with beta-lactams should receive TDM
次要结局
- Determinants of beta-lactam TDM implementation(Baseline)
研究者
研究点 (3)
Loading locations...
相似试验
已完成
不适用
Patient and Provider Attitudes in the Healthcare ContextHypertensionDiabetes MellitusNCT00404027VA Office of Research and Development300
Unknown
不适用
Beta-lactam Therapeutic Drug Monitoring in SingaporeInfection, BacterialNCT04450680Singapore General Hospital80
已完成
不适用
Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer TreatmentsNon-small Cell Lung Cancer (NSCLC)NCT06448793Bristol-Myers Squibb650
招募中
不适用
Routinely Collected Clinical Data and Evaluation of Antimicrobial Target AttainmentInfections, BacterialPharmacokineticsDrug MonitoringDrug-Related Side Effects and Adverse ReactionsNCT06427317Imperial College London323
已完成
不适用
i-Minds Professional Stakeholders Qualitative StudyChild Sexual Abuse, Confirmed, SequelaNCT05006053Sandra Bucci26